🎉 Congratulations to deepull for these promising results! 🚀 At Loop Dx, we are convinced that integrating these molecular devices, which identify specific pathogens, with our point-of-care diagnostic aid SeptiLoop—designed for the early detection of sepsis in emergency settings—could significantly enhance the management of septic patients. 🩺🔬
🚀 Promising Advances in Bloodstream Infection Diagnostics at ID Week 🧬 deepull shared preliminary clinical data at ID Week showing 94% positive percent agreement with blood culture. The UllCORE BSI direct from blood test detected 60 of 64 pathogens found by blood culture. Additionally, we detected 23 pathogens missed by the initial blood culture but found in a subsequent blood culture or other culture. These data suggest that the UllCORE BSI test is shaping up to provide additional clinical value by besting blood culture's sensitivity and turnaround time. #IDWeek #BloodstreamInfection #Diagnostics #UllCORE #HealthcareInnovation